Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Cross-sectional survey of awareness and intention in a single university cohort with low actual vaccination rates; descriptive and exploratory rather than comparative, and provides no interventional evidence.
Cross-sectional survey identifying psychosocial correlates of vaccine acceptability in a specific population; lacks comparator, intervention, or outcome follow-up, providing foundational evidence for intervention design rather than practice-changing guidance.
A sound cross-sectional study with adequate sample size and validated statistical methods (hierarchical regression and SEM) identifying psychosocial predictors of HPV vaccination intention in a specific population, but using intention as a surrogate for actual vaccination behavior and limited to one Chinese city.
Single-center mechanistic study with small sample size (n=4 for single-cell analysis) characterizing HPV-specific T-cell populations; functional validation of TCRs supports hypothesis but lacks clinical endpoint data or comparative outcome analysis.
Cross-sectional study with 893 participants demonstrates reduced post-vaccination HPV prevalence and identifies expected risk factors, reinforcing established vaccination strategies.
Preclinical murine tumor model study demonstrating HPV16 E7 mRNA/LNP vaccine efficacy in early-intervention setting, with no human data or comparator arm against standard therapy.
Retrospective analysis of national administrative health data quantifying HPV-attributable cancer burden in Peruvian men; provides population-level estimates but lacks a comparator group and relies on attributable fractions applied to observational data rather than direct measurement.